4.5 Article

Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects

期刊

CYTOKINE
卷 169, 期 -, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2023.156287

关键词

Cytokine storm; TNF-& alpha;; IFN-& gamma;; IL-6; IL-18; GM-CSF; G-CSF; Mesenchymal stem cell therapy; Therapeutic plasma exchange

向作者/读者索取更多资源

Since the initial cases were reported in Wuhan, China, in 2019, COVID-19 has caused millions of deaths during the last 3 years. Patients with COVID-19 experience severe pneumonia, high fever, acute respiratory distress syndrome (ARDS), and multiple-organ dysfunction, which can be fatal. Cytokine storm (CS) is a hyperactivation of the immune system, leading to excessive immune cell infiltrations in the lungs and other organs, causing tissue damage. Controlling the CS is crucial in treating COVID-19, and various strategies such as monoclonal antibodies, combination therapies, and stem cell therapy are employed.
COVID-19 has claimed millions of lives during the last 3 years since initial cases were reported in Wuhan, China, in 2019. Patients with COVID-19 suffer from severe pneumonia, high fever, acute respiratory distress syndrome (ARDS), and multiple-organ dysfunction, which may also result in fatality in extreme cases. Cytokine storm (CS) is hyperactivation of the immune system, wherein the dysregulated production of proinflammatory cytokines could result in excessive immune cell infiltrations in the pulmonary tissues, resulting in tissue damage. The immune cell infiltration could also occur in other tissues and organs and result in multiple organs' dysfunction. The key cytokines implicated in the onset of disease severity include TNF-a, IFN-?, IL-6, IL-18, GM-CSF, and GCSF. Controlling the CS is critical in treating COVID-19 disease. Therefore, different strategies are employed to mitigate the effects of CS. These include using monoclonal antibodies directed against soluble cytokines or the cytokine receptors, combination therapies, mesenchymal stem cell therapy, therapeutic plasma exchange, and some non-conventional treatment methods to improve patient immunity. The current review describes the role/s of critical cytokines in COVID-19-mediated CS and the respective treatment modalities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据